Viatris VTRS
NASDAQ VTRS
$20.86 +0.01 (+0.05%)
As of: Nov 11, 2026 · 9:45 AM EST

Viatris (VTRS) Goodwill impairment charges (2024 - 2025)

Updated

Viatris (VTRS) recorded Goodwill impairment charges of $2.94 billion in FY2025, up 814.9% from $321 million in FY2024.

Analysis

Viatris (VTRS) Goodwill impairment charges (2024 - 2025) Analysis & Trends

  • Per Business Quant data, VTRS's Goodwill impairment charges was $321 million in FY2024 (-44.7%) and $580.1 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Viatris 23.90 Bn 17.07 Bn 1.44 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.20 Mn
Mar 31, 2025 2.94 Bn
Jun 30, 2024 321.00 Mn
API Access

Viatris Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=VTRS&period=max&api_key=YOUR_API_KEY